These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4566268)

  • 1. Fibrin degradation products in renal parenchymal disease states and renal transplant patients.
    Shah BC; Ambrus JL; Mink IB; Albert DJ; Sampson D; Murphy GP
    Transplantation; 1972 Dec; 14(6):705-10. PubMed ID: 4566268
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary fibrin-fibrinogen degradation products and acute renal-transplant rejection.
    Lameire N; Baele G; Hilderson J; Ringoir S
    Lancet; 1973 Jul; 2(7821):160-1. PubMed ID: 4124092
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary excretion of heterophile (sheep) haemagglutinins and fibrin-fibrinogen degradation products after renal transplantation and in proliferative glomerulonephritis.
    Hoq MS; Clarkson AR; Anderton JL; Cash JD
    Lancet; 1973 May; 1(7811):1029-31. PubMed ID: 4122111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum and urine fibrin split products and urinary beta-glucuronidase in the diagnosis of renal transplant rejection.
    Gonick HC; Stiehm ER; Saldanha LF
    Curr Probl Clin Biochem; 1979; (9):257-72. PubMed ID: 376226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial estimation of urinary fibrin fibrinogen degradation products in kidney transplantation.
    Hall CL; Pejhan N; Thomson RW; Dawson-Edwards P; Barnes AD; Robinson BH; Meynell MJ; Blainey JD
    Br Med J; 1973 Jul; 3(5873):204-7. PubMed ID: 4578136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid latex-screening test for detection of fibrin-fibrinogen degradation products in urine after renal transplantation.
    Hulme B; Pitcher PM
    Lancet; 1973 Jan; 1(7793):6-8. PubMed ID: 4118584
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy.
    Hedner U
    Scand J Clin Lab Invest; 1973 Oct; 32(2):175-82. PubMed ID: 4588514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta2-microglobulin--immunological and nephrological aspects (review of the literature)].
    Galaĭ BM
    Vrach Delo; 1984 Mar; (3):76-80. PubMed ID: 6372245
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of intrarenal fibrin deposition.
    Davison AM; Thomson D; Macdonald MK; Rae JK; Uttley WS; Clarkson AR
    J Clin Pathol; 1973 Feb; 26(2):102-12. PubMed ID: 4572392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrin (ogen) Split products of nephropathies].
    Anger H
    Urologe A; 1975 Jan; 14(1):20-4. PubMed ID: 234643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinogen-fibrin degradation products in the urine. Measurement and characterization by means of electroimmunodiffusion (rapid method)].
    Thöni RF; Grob PJ
    Schweiz Med Wochenschr; 1973 Jul; 103(27):965-9. PubMed ID: 4146017
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latex-screening test for urinary F.D.P.
    Clarkson AR
    Lancet; 1973 Jan; 1(7794):109. PubMed ID: 4118640
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary FDP, heterophile agglutinins IgG, IgM, and C3 in renal homotransplant rejection and glomerulonephritis.
    Anderton JL; Hoq MS; Clarkson AR; Cash JD
    Proc Eur Dial Transplant Assoc; 1973; 10(0):500-7. PubMed ID: 4607330
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kidney transplant rejection and the original kidney disease of the recipient].
    Nizze H; Brockmöller S
    Verh Dtsch Ges Pathol; 1989; 73():233-7. PubMed ID: 2482607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Assessment of human renal transplantation.
    Ward PD
    Lancet; 1974 Nov; 2(7890):1211. PubMed ID: 4139627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.